Video

Dr. George D. Demetri on the Importance of Collaboration in Sarcoma

George D. Demetri, MD, senior vice president for Experimental Therapeutics at the Dana-Farber Cancer Institute, professor of Medicine at Harvard Medical School, and co-director of the Ludwig Center at Harvard, discusses the importance of collaboration in sarcoma.

While there has not really been anything practice-changing recently in sarcoma, there has recently been a coalescing of the continuum of science: from the most basic discovery scientists, who deal with worms and basic mechanisms of DNA and enzymes, all the way up to the most clinical of clinicians, said Demetri.

There is an effort to make a true continuum between the basic scientists and clinical scientists, and the pediatric and adult oncologists in the sarcoma space. The changes in practice could not have happened without the advances in basic science, academic investigators, and the industrialists who are really trying to derive it to practice-changing methods, said Demetri.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Alvaro Alencar, MD, discusses current unmet needs following the development of covalent BTK inhibitor resistance in CLL.
Melanie A. Sheen, MD
Raajit Rampal, MD, director of the Center for Hematologic Malignancies and director of the Myeloproliferative Neoplasms Program at Memorial Sloan Kettering Cancer Center
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Jordyn Silverstein, MD
Rachel N. Grisham, MD
Toon Van Gorp, MD, PhD
R. Lor Randall, MD, FACS
Joshua Richter, MD of Tisch Cancer Institute